Hedera Dx

Epalinges, Switzerland · Founded 2021 · Privately Held (backing)

Operator of a global cancer real-world data platform designed to enable molecular testing and AI-driven insights for improved cancer care outside the US. Hedera Dx is based in Epalinges, Switzerland and was founded in 2021. Its last reported valuation was $43 million in Mar 2024. It has raised $36.8 million.

Last reported valuation

$43.0M

Oct 2026

Priced at

—

Total raised

$36.8M

Last round

—

How much has Hedera Dx raised?

$36.8Macross 0 recorded rounds

Free account

More of Hedera Dx with a free account

·The complete investor list: 11 names
·Watch Hedera Dx: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Hedera Dx investors

11 investors are on record for Hedera Dx, including TA Ventures, Tesi, VSquared Ventures and GRIDS Capital.

For fundraisers

Raising for a company like Hedera Dx?

11 investors have backed Hedera Dx.

See all 11 investors →

Frequently asked about Hedera Dx

How much has Hedera Dx raised?: Hedera Dx has raised $36.8M in total across 0 recorded funding rounds.